Document is current
Any future updates will be listed below
-
Authors
Nakamaru, Ryo
Hara, Akitoshi
Yamada, Yuji
Sawano, Mitsuaki
Yamamoto, Koichi
- License Information
-
More Information
Article History
Received: 22 May 2025
Revised: 28 August 2025
Accepted: 15 September 2025
First Online: 17 October 2025
Compliance with ethical standards
:
: MS has been partially supported by research funding from Polybio, Pfizer in the past three years, and Novartis. He has also received lecture honoraria from Boehringer Ingelheim. KY has been supported by research funding from Boehringer Ingelheim, Novartis, and Eli Lilly. He has also received lecture honoraria from DAIICHI SANKYO, INC., Novartis, and Otsuka Pharmaceutical Co., Ltd. The other authors report no conflicts of interest.
